Search

Author/Creator Kinney, G.G.

1. OP0205 Clinical and Preclinical Assessment of The Anti-MCAM Monoclonal Antibody PRX003, A Potential Novel Treatment for Th17-Mediated Inflammatory Diseases. (15th July 2016)

Authors:
Koller, M.; Flanagan, K.; Skov, M.; Goldblum, R.; Griffith, S.G.; Barbour, R.M.; Ehsani-Chimeh, N.; Marinkovich, M.P.; Zago, W.; Yednock, T.A.; Kinney, G.G.; Ness, D.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 75(2016)Supplement 2
Page Start:
134
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Results from a phase 1b multiple ascending-dose study of PRX002/RG7935, an Anti-alpha-synuclein monoclonal antibody, in patients with Parkinson's disease. (January 2018)

Authors:
Jankovic, J.; Goodman, I.; Safirstein, B.; Schenk, D.B.; Kinney, G.G.; Koller, M.; Ness, D.K.; Griffith, S.G.; Grundman, M.; Soto, J.; Ostrowitzki, S.; Boess, F.G.; Martin-Facklam, M.; Quinn, J.F.; Issacson, S.H.; Jennings, D.; Omidvar, O.; Ellenbogen, A.
Journal:
Parkinsonism & related disorders
Issue:
Volume 46(2018)Supplement 2
Page Start:
e25
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗